Pharmacy Continence Care - Bladder and Bowel Website

Figure 11: Pharmacy responses to PIQ and PEQ Question 5 – understanding of
the risk factors for bladder and bowel incontinence ............................................. 25
Figure 12: Pharmacy responses to PIQ and PEQ Question 6 – understanding of
medicines used in the treatment of incontinence ................................................. 25
Figure 13: Pharmacy responses to PIQ and PEQ Question 7 – understanding of
medicines that may cause or exacerbate incontinence ......................................... 26
Figure 14: Pharmacy responses to PIQ and PEQ Question 8 – confidence in
initiating a conversation with customers who may have incontinence ................... 26
Figure 15: Pharmacy responses to PIQ and PEQ Question 9 – providing
appropriate referrals for customers who disclose or admit to having a
continence problem ........................................................................................... 26
Figure 16: Pharmacy responses to PIQ and PEQ Question 10 – understanding of
self-management options for people with incontinence........................................ 27
Figure 17: Pharmacy responses to PIQ and PEQ Question 11 – confidence in
providing advice about self-management options such as diet and
exercise that promote continence....................................................................... 27
Figure 18: Pharmacy responses to PIQ and PEQ Question 12 – understanding of
the different incontinence equipment and products and how to match
these to the specific needs of customers............................................................. 27
Figure 19: Pharmacy responses to PIQ and PEQ Question 22 – rating of current
level of knowledge about incontinence................................................................ 28
Figure 20: Pharmacies’ rating of knowledge and skills before and after training................... 28
Figure 21: Average satisfaction rating............................................................................... 29
Figure 22: Degree to which the Program met pharmacies’ expectations .............................. 30
Figure 23: Pharmacies’ rating of the usefulness of the Program.......................................... 30
Figure 24: Pharmacies’ rating of degree of usefulness in providing better
continence services ........................................................................................... 32
Figure 25: Rating of the training modules ......................................................................... 32
Figure 26: Value of sales in the previous month ................................................................ 35
Figure 27: Level of pharmacy knowledge about incontinence ............................................. 35
Figure 28: Pharmacy reported cost of training ................................................................... 37
APPENDICES
Appendix 1: Methodology details
1.1 Detailed methodology
1.2 Timelines
1.3 List of participating pharmacies
1.4 Training materials
1.4.1 Website
1.4.2 Training manual
Final Report vi NOVA Public Policy
Pharmacy Continence Care Project